IEEE International Conference on Computing and Machine Intelligence · Apr 9, 2026

A Novel AI Approach to Investigate Curcumin’s Potential to Delay Alzheimer’s Onset Using Genetically Modified Drosophila

By Fan Z, Jin S

This study examines the efficacy of curcumin, a natural polyphenolic compound derived from the turmeric plant, in helping to reduce inflammation and Alzheimer’s disease (AD) symptoms. Three experimental groups of Drosophila were used for testing: GAL4 Drosophila (control group), Drosophila acquiring AD-like symptoms, and Drosophila acquiring AD-like symptoms after curcumin treatment. Two tests were conducted to measure the health of the flies: a climbing assay test and a petri dish performance assay. Both tests use Drosophila’s movement to measure health. This study has developed an AI-based solution with identified behavioral indicators that calculates the speed and height of Drosophila. The Drosophila given curcumin in their diet was relatively more active than the others. The developed AI, OpenCV, calculated results from movement across all three testing groups. The AI OpenCV method used in this project was applied in a novel way by using its image analysis capabilities to measure and compare behavioral or cognitive pattern changes related to curcumin’s potential to delay Alzheimer’s progression, rather than for traditional object detection tasks. The Drosophila given curcumin showcased a significant increase in health, living 30% longer. The Drosophila that acquired Alzheimer-like symptoms with standard fly food died relatively quickly. They showed weaker performance in both assays due to slower mobility and relatively lower health levels. In both tests, the Drosophila that acquired Alzheimer-like symptoms with curcumin in their food moved approximately 5.5 times quicker and had progressively improved health. The results of this study demonstrate that curcumin powder increases speed and movement by 5.5-fold greater than untreated models. Statistical analysis showed highly significant differences between curcumin-treated flies and Drosophila acquiring Alzheimer-like symptoms (p = 0.0086), indicating curcumin’s positive effects. Comparing the control group and the group acquiring Alzheimer-like symptoms also showed high significance (p = 0.0075), confirming successful breeding of Drosophila. There was an insignificant difference between the curcumin group and the control group, suggesting curcumin restored normal health levels. This study illuminate’s curcumin’s efficacy and efficiency in delaying the progression of Alzheimer’s due to its anti-inflammatory and antioxidant properties. This study also demonstrates the immediate effect of an AI-based solution to support the Alzheimer's drug and nutrition study.

doi.org/10.1109/icmi68585.2026.11539852Interventions

AgingResearch.News